Congress
$1,001–$15,000
Traded Feb 10 · disclosed 30 days later
3 different filers disclosed HUM within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 23, 2026 · Filed Feb 25, 2026
Humana's President, CenterWell paid $150K out of pocket for Humana shares. Shares held went up 8% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$150,016
Shares × reported transaction price
$100K–$500K
+7.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 1.6% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2025 ($9.39M)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-03-06. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
12 days after results of Feb 11, 2026, 65 days before results of Apr 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $181.16 on Feb 23, 2026, within 4% of its 52-week low, after a 35% drop over the previous 30 trading days
52-week range $175.40 (Feb 11, 2026) to $312.00 (Sep 4, 2025), 4% of the way up, from 251 adjusted closes. 30 trading days earlier: $277.57 on Jan 8, 2026. Describes the past only, not a forecast
RSI 30, 28% under its 200-day average, 24% under its 50-day average, 42% below the 52-week high, 20-day volatility 92% a year, against the S&P 500: −31 points over 1 month, −24 points over 3 months, −46 points over 6 months
From the adjusted closes up to Feb 23, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Sanjay K Shetty's first open-market purchase of HUM in filings since 2006
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
A securities lawsuit naming the company as a defendant was filed on Jul 31, 2024 in the U.S. District Court, D. Delaware. A filing is an allegation, not a finding.
2 such cases were open. Marathe v. Humana Inc., docket 1:24-cv-00898, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.3% | −1.2% | −2.1% |
| 30 days | −11.2% | −8.3% | −2.8% |
| 90 days | +63.9% | +8.9% | +55.1% |
| 180 days | +108.6% | +11.1% | +97.5% |
Past results only. Not a forecast.
Congress
Traded Feb 10 · disclosed 30 days later
3 different filers disclosed HUM within 90 days.
Insider filing
Traded Feb 24 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Feb 24 · filed 2 days later
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.